Navigation Links
Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting
Date:10/29/2009

the overall percent weight loss in the EQUIP study was 11% for patients on full dose Qnexa, as compared to 1.6% for the placebo group."

Also included in the presentation were discontinuation rates for cognitive events. Overall, these rates were low and the events were generally mild to moderate and reversible with discontinuation of treatment. There was one severe event in the treatment arm and one in the placebo arm that led to discontinuation. Specifically, the discontinuation rates for various cognitive-related events were as follows:


    % of Patients             EQUIP (n=1,264)           CONQUER (n=2,485)
    -------------       ------------------------    -------------------------
    MedDRA Preferred               Qnexa   Qnexa               Qnexa    Qnexa
     Terms              Placebo     Low     Full    Placebo     Mid     Full
    ----------------    -------    -----   -----    -------    -----    -----
    Disturbance in
     Attention             0.4%     0.0%     1.4%      0.1%     0.0%     0.7%
    Memory Impairment      0.0%     0.0%     0.0%      0.1%     0.0%     0.5%
    Amnesia
     (forgetfulness)       0.2%     0.0%     0.6%      0.0%     0.2%     0.3%
    Aphasia (word
     finding
     difficulties)         0.0%     0.0%     0.2%      0.0%     0.0%     0.3%
    Cognitive Disorder     0.2%     0.0%     0.0%      0.0%     0.0%     0.2%
    Confusional State      0.0%     0.4%     0.2%      0.1%     0.2%     0.1%
    Bradyphrenia
     (slow thinking)       0.0%     0.0%     0.2%      0.0%     0.0%     0.0%
    Disorientation         0.0%     0.0%     0.0%      0.0%     0.0%     0.0%
    Mental Impairment      0.0%     0.0%     0.0%      0.0%     0.0%     0.0%

    Events are not additive as some patients have reported more than one event
    leading to study drug discontinuation.

Consistent with standard scientific and regulatory methodologies, these infrequent events that lead to study drug discontinuati
'/>"/>

SOURCE VIVUS, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
2. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
3. First Osteoporosis Study in Hip Fracture Patients Finds Once-Yearly Reclast(R) Prevents Additional Fractures and Improves Survival
4. PTC Therapeutics Announces Additional Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy
5. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
6. Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical Development
7. Progen Presents Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases
8. Pharmacopeia Announces Additional Positive Findings from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
9. Sulodexide Data Safety Monitoring Committee Completes Additional Review of Phase 3 Study Data
10. Indevus Reports Additional Positive Phase III Trial Data for NEBIDO(R)
11. Paul Capital Healthcare Purchases Additional Royalty Interest in GlaxoSmithKlines Rotarix(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... 21, 2014 /CNW/ - Bedrocan Cannabis Corp., previously Bedrocan ... to its Board of Directors, enhancing executive oversight ... company, a leading licensed producer of medicinal cannabis ... has 13 years, experience in producing and supplying ... including Canada. As previously announced ...
(Date:8/21/2014)... Aug. 21, 2014  SI-BONE, Inc. ( San ... pioneered the use of the iFuse Implant System, ® ... fusion of the sacroiliac (SI) joint, announced that Priority ... to its Lumbar Fusion Medical Policy No. 91590-R4 providing ... The policy states that the fusion procedure, which employs ...
(Date:8/20/2014)... Aug. 20, 2014 Northstar Global Business ... after months of hard work from many talented ... Snorenz formulation and package design.  The new formulation ... back into the product due to overwhelming evidence ... effects.  Snorenz Nighttime will also include these vitamins, ...
Breaking Medicine Technology:Senior Life Sciences Executives Join Bedrocan as Independent Directors 2Senior Life Sciences Executives Join Bedrocan as Independent Directors 3SI-BONE, Inc. Announces Positive Coverage Decision by Priority Health 2SI-BONE, Inc. Announces Positive Coverage Decision by Priority Health 3Northstar completes the first phase of its new retail strategy and prepares to ship reformulated Snorenz with all new packaging 2
... scans used to,track changes in a dozen patients who ... brain function -- and the effects are,still present a ... MD, of The Feinstein Institute,for Medical Research collaborated with ... and others to deliver genes for,glutamic acid decarboxylase (or ...
... it acoustic trauma or,noise-induced hearing loss. By any name, ... Up to 28 million Americans,have impaired hearing; for as ... reports the December 2007 issue of Harvard Men,s,Health Watch., ... On-the-job noise exposure,is the most common cause, but recreational ...
Cached Medicine Technology:PET Scans Show Gene Therapy Normalizes Brain Function in Parkinson's Patients 2PET Scans Show Gene Therapy Normalizes Brain Function in Parkinson's Patients 3Your Hearing May be at Risk, Says Harvard Men's Health Watch 2
(Date:8/22/2014)... The rising numbers of teenage substance ... the years, countless lives have been lost due to adolescent ... the community a new helpline was established to provide a ... Ohio who are seeking to overcome their chemical dependency issues. ... (300) 400-2616, parents and their teens can speak immediately to ...
(Date:8/22/2014)... Aid in Recovery, a full service drug and ... recent bill introduced in the Philippines House ... and retired police general. In House Bill 4451, Pagdilao ... than imprisonment. Aid in Recovery points to this bill ... drug addiction epidemic. , The bill, introduced this summer, ...
(Date:8/22/2014)... Lexington, North Carolina (PRWEB) August 22, 2014 ... United Church Homes and Services (UCHS ), recently ... frail and at risk seniors with limited resources in ... open floor plan, fully operational kitchen, individually controlled heating ... The HUD Section 202 supportive housing community, consists of ...
(Date:8/21/2014)... Os-Monitor.com, an outstanding online supplier of useful ... software collection ( http://www.os-monitor.com ). In addition to ... these high end items are offered with greatly ... improving productivity, the employers pay more attention to ... and network monitoring software products are becoming more ...
(Date:8/21/2014)... (PRWEB) August 22, 2014 The natural loss ... fine lines, wrinkles and sagging of skin. Using products ... "By age 40, the body has lost about 15% of ... about 45%," says Kathy Heshelow, founder of Sublime Beauty®. ... of it - well, we know what happens." , Collagen ...
Breaking Medicine News(10 mins):Health News:Troubled Teens in Akron, OH Can Receive Assistance from New Helpline for Addiction Recovery 2Health News:Proposed Legislature in the Philippines Highlights the Need for Rehabilitation, Not Incarceration, for Drug Users, Says Aid in Recovery 2Health News:Proposed Legislature in the Philippines Highlights the Need for Rehabilitation, Not Incarceration, for Drug Users, Says Aid in Recovery 3Health News:United Church Homes and Services Announce New Affordable Housing Community for Seniors 2Health News:New Employee Monitoring Software Collection Unveiled By Os-Monitor.com 2Health News:4 Skincare Products That Boost and Nurture Collagen on Sale at Sublime Beauty® 2Health News:4 Skincare Products That Boost and Nurture Collagen on Sale at Sublime Beauty® 3
... of men as an erectile dysfunction (ED) medication for ... rates of// patient and partner satisfaction. However, Researchers have ... ,Recent reports have appeared about some individuals ... narcotics such as methamphetamines. These reports further note that ...
... the leaders of the world system are falling short of pennies ... poorest of the poor communities marred by diabetes from snow diving ... the form of appropriate care when compared to those who suffer ... ,Statistics reveal that Over two million people are diagnosed ...
... Freddie and Thomas Greenstreet were born two weeks ago ... genetic haplotyping that screens for genetic// diseases. ... cystic fibrosis (CF). Pre-implantation genetic haplotyping looks for a ... disease, Huntington's disease, Duchenne muscular dystrophy and spinal muscular ...
... (ACS) has planned to celebrate the 30th anniversary of ... objective of the Great American Smokeout over the past ... dangers of tobacco use as well as the challenges ... want to quit are urged to call the American ...
... released in the state of Pennsylvania, U.S,reveals that there were ... 2005.// ,The report the first of ... various hospitals spread all over the state released in Pennsylvania ... hospital acquired infections when admitted there for some treatment or ...
... platelet-depleting autoimmune disease in a whole new way, ... thrombocytopenic purpura (ITP) once again// produce healthy amounts ... ,That's the conclusion of a new, ... professor of pediatrics at Weill Cornell Medical College, ...
Cached Medicine News:Health News:HIV and Erectile Medications - No Link Found 2Health News:Poor diabetics: bitter times and worse times with no sweet respite 2Health News:First Embryos in UK Screened for Disease 2Health News:Hospital infections gaining ground in Pennsylvania hospitals 2Health News:Drug Boosts Platelet Production, Reversing Immune Thrombocytopenic Purpura 2Health News:Drug Boosts Platelet Production, Reversing Immune Thrombocytopenic Purpura 3
... and Quality Assurance (for Waived and PPM ... clinics and small hospitals maintain laboratory excellence. ... patient lab results and assist labs in ... to earn 12 P.A.C.E. Contact hours per ...
An enzyme linked immunosorbent assay (ELISA) for the detection and quantitationof RF IgG isotype in human serum of patients with rheumatoid arthritis....
An enzyme linked immunoassay (ELISA) for the detection and semiquantitationof IgG and IgM antibodies to 2-GP1, as an aid in assessingthe risk of thrombosis in patients with Systemic Lupus Erythematos...
An enzyme linked immunoassay (ELISA) for the detection and semiquantitation of IgG, IgA or IgM anticardiolipin antibodies, as an aid in assessing the risk of thrombosis in individuals with Systemic L...
Medicine Products: